You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
About Kedrion - Front Image

kedrion group eurobond

Maturity 24th April 2019 - XS1061608300

On April 16th, Kedrion Group S.p.A. successfully completed the issuance of a 300 million euro senior, unsecured and unrated debenture loan, which will be due April 2019. They are fixed-rate securities with a 4.625% coupon p.a.. Issue price is at par (100%). With a minimum denomination of 100,000 euros, such bonds have been placed with leading international institutional investors and have been listed on the Irish Stock Exchange by the date of accrual, April 24th 2014.

Bond Quotes


FY2015 Earnings call

Teleconference on May 11, 2016. Please see how to register.

read more 

Kedrion Biopharma strengthens its position on the US market

Granted exclusive rights to commercialize a lifesaving drug in the US

read more 

Kedrion Notes 2019 Tender Offer results

Kedrion has decided to accept for purchase Notes validly tendered for a total aggregate principal amount equal to €150,716,000

read more 
For more information please contact: